Cargando…

Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer

As we age, the composition of our peripheral leukocytes changes dramatically. Many of these alterations contribute to the general immune dysfunction that burdens the elderly, which in turn, contributes to increased susceptibility to disease. MDSCs represent a heterogeneous population of immunosuppre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verschoor, Chris P., Johnstone, Jennie, Millar, Jamie, Dorrington, Michael G., Habibagahi, Mojtaba, Lelic, Alina, Loeb, Mark, Bramson, Jonathan L., Bowdish, Dawn M. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Leukocyte Biology 2013
Materias:	Translational & Clinical Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701116/ https://www.ncbi.nlm.nih.gov/pubmed/23341539 http://dx.doi.org/10.1189/jlb.0912461

Ejemplares similares

Alterations to the Frequency and Function of Peripheral Blood Monocytes and Associations with Chronic Disease in the Advanced-Age, Frail Elderly
por: Verschoor, Chris P., et al.
Publicado: (2014)

Immunosenescence in the nursing home elderly
por: Johnstone, Jennie, et al.
Publicado: (2014)

An Introduction to Automated Flow Cytometry Gating Tools and Their Implementation
por: Verschoor, Chris P., et al.
Publicado: (2015)

The Polyfunctionality of Human Memory CD8+ T Cells Elicited by Acute and Chronic Virus Infections Is Not Influenced by Age
por: Lelic, Alina, et al.
Publicado: (2012)

Myeloid-derived suppressor cells, age and cancer
por: Bowdish, Dawn ME
Publicado: (2013)

Immunosuppressive role of CD11b(+)CD33(+)HLA‐DR(−) myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
por: Hyun, Shin Young, et al.
Publicado: (2020)

CD33(+) HLA-DR(–) Myeloid-Derived Suppressor Cells Are Increased in Frequency in the Peripheral Blood of Type1 Diabetes Patients with Predominance of CD14(+) Subset
por: Hassan, Mirhane, et al.
Publicado: (2018)

Intratumoral HLA-DR(−)/CD33(+)/CD11b(+) Myeloid-Derived Suppressor Cells Predict Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Hasnis, Erez, et al.
Publicado: (2020)

Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection
por: Tang, Fan, et al.
Publicado: (2020)

The HLA-DRα Chain Is Modified by Polyubiquitination
por: Lapaque, Nicolas, et al.
Publicado: (2009)

Immunosenescence and Novel Vaccination Strategies for the Elderly
por: Dorrington, Michael G., et al.
Publicado: (2013)

Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity
por: Pawelec, Graham, et al.
Publicado: (2019)

HLA‐A*33‐DR3 and A*33‐DR9 haplotypes enhance the risk of type 1 diabetes in Han Chinese
por: Zhang, Juanjuan, et al.
Publicado: (2016)

TGF-β Enhances the Anti-inflammatory Effect of Tumor-Infiltrating CD33+11b+HLA-DR Myeloid-Derived Suppressor Cells in Gastric Cancer: A Possible Relation to MicroRNA-494
por: Moaaz, Mai, et al.
Publicado: (2020)

Estimating SARS-CoV-2 seroprevalence in long-term care: a window of opportunity
por: Verschoor, Chris P, et al.
Publicado: (2022)

Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy
por: Tazzari, M, et al.
Publicado: (2014)

Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator
por: Oliver, Liliana, et al.
Publicado: (2022)

Immune independent crosstalk between lymphoma and myeloid suppressor CD14(+)HLA-DR(low/neg) monocytes mediates chemotherapy resistance
por: Zhang, Zhe (Jenny), et al.
Publicado: (2015)

The impact of respiratory infections and probiotic use on the nasal microbiota of frail residents in long-term care homes
por: Bowdish, Dawn M.E., et al.
Publicado: (2023)

Identification of CD8(+) T Cell Epitopes in the West Nile Virus Polyprotein by Reverse-Immunology Using NetCTL
por: Larsen, Mette Voldby, et al.
Publicado: (2010)

Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice
por: Chandra, D, et al.
Publicado: (2013)

CD14(+) CD15(−) HLA-DR(−) myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure
por: Bernsmeier, Christine, et al.
Publicado: (2018)

Clinical significance of peripheral blood CD11b(+)/CD33(+)/HLA-DR(-) myeloid cells in infants and children with infectious diseases and increased CRP
por: Latifi, Aysan, et al.
Publicado: (2020)

Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy
por: Cook, Katherine W, et al.
Publicado: (2021)

Ascites-derived IL-6 and IL-10 synergistically expand CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in ovarian cancer patients
por: Wu, Liangliang, et al.
Publicado: (2017)

An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer
por: O'Donnell, Charlotte, et al.
Publicado: (2016)

Microneutralization Assay Titres Correlate with Protection against Seasonal Influenza H1N1 and H3N2 in Children
por: Verschoor, Chris P., et al.
Publicado: (2015)

Correction: Microneutralization Assay Titres Correlate with Protection against Seasonal Influenza H1N1 and H3N2 in Children
por: Verschoor, Chris P., et al.
Publicado: (2016)

T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia
por: Hoseini, Sayed Shahabuddin, et al.
Publicado: (2021)

Mycoplasma pneumoniae, a trigger for Weston Hurst syndrome
por: Magun, Rick, et al.
Publicado: (2016)

Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma
por: Chuntova, Pavlina, et al.
Publicado: (2022)

Dr. Julius Kratter on the Elimination of Strychnia through the Urine
por: Kratter, Julius
Publicado: (1882)

Increased CD14(+)HLA-DR(−/low) Myeloid-Derived Suppressor Cells Correlate With Disease Severity in Systemic Lupus Erythematosus Patients in an iNOS-Dependent Manner
por: Wang, Zhitao, et al.
Publicado: (2019)

Circulating CD14(+)HLA-DR(−/low) Myeloid-Derived Suppressor Cells as Potential Biomarkers for the Identification of Psoriasis TCM Blood-Heat Syndrome and Blood-Stasis Syndrome
por: Sun, Shipeng, et al.
Publicado: (2020)

HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules
por: Denzin, Lisa K., et al.
Publicado: (1996)

Association of HLA-DR1, HLA-DR13, and HLA-DR16 Polymorphisms with Systemic Lupus Erythematosus: A Meta-Analysis
por: Wang, Tingrui, et al.
Publicado: (2022)

Characterization of the T cell response to hnRNP-A2 (RA33) in HLA-DR4 transgenic mice
por: Hoffmann, M, et al.
Publicado: (2004)

Host cytokine responses distinguish invasive from airway isolates of the Streptococcusmilleri/anginosis group
por: Kaiser, Julienne C, et al.
Publicado: (2014)

Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation
por: Ballou, Cassandra, et al.
Publicado: (2023)

2456 Cutaneous lupus erythematosus patients have increased circulating myeloid-derived suppressor cells with immunosuppressive properties
por: Florez-Pollack, Stephanie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0eved8jpc4ijnbfac9r0s4vk2d